| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/22/1998 | CN1179716A Low dose ridogrel formulations and their use for treatment of inflammatory bowel diseases |
| 04/22/1998 | CN1179715A Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections |
| 04/22/1998 | CN1179714A Treating urinary incontinence using (s)-oxybutynin and (s) -desethyloxybutynin |
| 04/22/1998 | CN1179713A Use of LCK SH2 specific compounds to treat autoimmune diseases and allograft rejection |
| 04/22/1998 | CN1179698A Micella nanoparticles |
| 04/22/1998 | CN1179424A Phthalocyanine Zn complex and its producing process and use for producing anti cancer medicine |
| 04/22/1998 | CN1179422A New flavone compounds, process for preparing them and pharmaceutical compositions containing them |
| 04/22/1998 | CN1179418A Novel cyloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/22/1998 | CN1179308A Injection for castrating animals |
| 04/22/1998 | CN1179307A Liquid antiacid compositions |
| 04/22/1998 | CN1179306A Medicine containing tripdiolide for preventing and treating graft acute rejection |
| 04/22/1998 | CN1038131C Pyrrolopyrimidines and its preparing intermediate and medicinal composition containing same and use |
| 04/22/1998 | CA2214677A1 Cephalosporin pyridinium derivatives |
| 04/21/1998 | US5741919 Highly branched |
| 04/21/1998 | US5741916 Meadowfoam alkanolamides |
| 04/21/1998 | US5741915 Amphoteric surfactants useful in personal care applications |
| 04/21/1998 | US5741910 Compounds which are selective antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools |
| 04/21/1998 | US5741907 Pharmacologically active enantiomers |
| 04/21/1998 | US5741902 7-acyl-3-(substituted carbamoyloxy) cephem compounds and process for their preparation |
| 04/21/1998 | US5741896 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 04/21/1998 | US5741821 Use of natural products and related synthetic compounds for the treatment of cardiovascular disease |
| 04/21/1998 | US5741819 Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors |
| 04/21/1998 | US5741818 Semicarbazones having CNS activity and pharmaceutical preparations containing same |
| 04/21/1998 | US5741815 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 04/21/1998 | US5741813 Administering substituted xanthones |
| 04/21/1998 | US5741811 Administering to cancer patients |
| 04/21/1998 | US5741810 Prostaglandins for ocular hypotension for treatment of glaucoma |
| 04/21/1998 | US5741809 Compounds and methods for the treatment of cardiovascular inflammatory and immune disorders |
| 04/21/1998 | US5741808 Protein kinase inhibitors for treatmen of neurological disorders |
| 04/21/1998 | US5741807 Histidine compositions and methods for treating or preventing infectious and non-infectious diarrheas |
| 04/21/1998 | US5741806 Suppository compositions containing ondasetron dihydrate |
| 04/21/1998 | US5741805 Controlled release pilocarpine delivery system |
| 04/21/1998 | US5741804 Substituted benzimazoles which inhibit platelet aggrecation |
| 04/21/1998 | US5741802 Anabaseine derivatives useful in the treatment of degenerative diseases of the nervous system |
| 04/21/1998 | US5741801 Ketone compounds with aromatic groups and amino groups |
| 04/21/1998 | US5741797 Heteroatom substituted alkyl benzylaminoquinuclidines |
| 04/21/1998 | US5741796 Pyridyl and naphthyridyl compounds for inhibiting osteoclast-mediated bone resorption |
| 04/21/1998 | US5741795 Administering to treat hyperandrogenic conditions, such as, acne vulgaris |
| 04/21/1998 | US5741794 Platelet activating factor |
| 04/21/1998 | US5741791 Administering compounds which inhibit secretion, circulation or effect of insulin antagonizing peptides; can be used to treat non-insulin-dependent diabetes mellitus |
| 04/21/1998 | US5741790 Tachykinin antagonist and intermediates for nervous system disorders, antiinflammatory agents, antiarthritic agents, antidepressants and gastrointestinal disorders |
| 04/21/1998 | US5741788 Heterocyclic compounds and their preparation and use |
| 04/21/1998 | US5741787 Psychological disorders |
| 04/21/1998 | US5741786 Steroids with a 17-spiromethylene lactone or lactol group |
| 04/21/1998 | US5741785 Imidazolo(1,2-a)quinoxalinone compounds; antiischemic agents; nervous system disorders |
| 04/21/1998 | US5741782 Mixture of bactericide and fungicide; decontaminating tissue for transplantation |
| 04/21/1998 | US5741779 Slowing clot formation in blood by administering bactericidal/permeability-increasing protein product |
| 04/21/1998 | US5741679 Regulatable nucleic acid therapeutic and methods of use thereof |
| 04/21/1998 | US5741673 Nucleic acid encoding a novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 04/21/1998 | US5741661 Screening assay |
| 04/21/1998 | US5741523 Stabilized prostaglandin E1 |
| 04/21/1998 | US5741515 Reaction product of phosphates and ketoprofen |
| 04/21/1998 | US5741507 Ranitidine tablet having a hydroxypropylmethylcellulose containing coating and a method for producing said coating |
| 04/21/1998 | US5741506 Use of active ingredients protected against degradation in the rumen as hepatoprotectors |
| 04/21/1998 | US5741503 Method for regulating metabolism with dopamine beta hydroxylase inhibitors |
| 04/21/1998 | US5741492 Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses |
| 04/21/1998 | US5741488 Treatment of rheumatoid arthritis with anti-CD4 antibodies in conjunction with anti-TNF antibodies |
| 04/21/1998 | US5741486 Safe vectors for gene therapy |
| 04/21/1998 | US5741480 Self-tanning cosmetic compositions |
| 04/21/1998 | CA2143301C N-(hydroxyethyl)butanediamide derivatives as renin inhibitors |
| 04/21/1998 | CA2143300C Renin inhibiting n-(2-amino-2-oxoethyl)butanediamide derivatives |
| 04/21/1998 | CA2087004C Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases |
| 04/21/1998 | CA2064687C Method and device for administering dexmedetomidine transdermaly |
| 04/18/1998 | CA2218782A1 Pharmaceutical compounds |
| 04/16/1998 | WO1998015575A1 Promoter for smooth muscle cell expression |
| 04/16/1998 | WO1998015574A1 Methods and compositions for generating angiostatin |
| 04/16/1998 | WO1998015568A2 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 04/16/1998 | WO1998015563A1 Tetraphosphonate bicyclic trisanhydrides |
| 04/16/1998 | WO1998015556A1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS |
| 04/16/1998 | WO1998015554A1 Acridone derivatives and method of preparation of 8-hydroxy imidazoacridinone derivatives |
| 04/16/1998 | WO1998015553A1 5-HETEROATOM-CONTAINING ALKYL SUBSTITUTED-3-OXO-PYRIDO(1,2-a) BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS |
| 04/16/1998 | WO1998015552A1 1H-PYRIDO[3,4-b]INDOLE-4-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS |
| 04/16/1998 | WO1998015550A1 N-substituted azaheterocyclic compounds |
| 04/16/1998 | WO1998015549A1 N-substituted azaheterocyclic compounds |
| 04/16/1998 | WO1998015548A1 1,4-disubstituted piperazines |
| 04/16/1998 | WO1998015547A1 Thio acid derived monocyclic n-heterocyclics as anticoagulants |
| 04/16/1998 | WO1998015546A1 N-substituted azaheterocyclic compounds |
| 04/16/1998 | WO1998015545A1 New serotonin 5-ht1f agonists |
| 04/16/1998 | WO1998015543A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same |
| 04/16/1998 | WO1998015542A1 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds |
| 04/16/1998 | WO1998015535A1 1,4-benzodiazepinones and their uses as cck antagonists |
| 04/16/1998 | WO1998015534A1 Novel pyrimidine derivatives and antitumor agents containing the same as the active ingredient |
| 04/16/1998 | WO1998015526A1 O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same |
| 04/16/1998 | WO1998015521A1 New pentaerythritol derivatives, their production and use and intermediates for their synthesis |
| 04/16/1998 | WO1998015295A2 Radiopharmaceuticals for imaging infection and inflammation |
| 04/16/1998 | WO1998015291A1 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof |
| 04/16/1998 | WO1998015290A1 PHARMACEUTICAL COMPOSITIONS COMPRISING HMG-CoA REDUCTASE INHIBITORS, IN PARTICULAR FLUVASTATIN |
| 04/16/1998 | WO1998015283A1 Agents for the regulation of oestrogen synthesis |
| 04/16/1998 | WO1998015280A1 New combination |
| 04/16/1998 | WO1998015279A1 Hormonal composition consisting of an oestrogen compound and of a progestational compound |
| 04/16/1998 | WO1998015278A1 Method for stimulating bone formation |
| 04/16/1998 | WO1998015277A2 Cns-penetrant nk-1 receptor antagonists as antidepressant and/or an anti-anxiety agents |
| 04/16/1998 | WO1998015276A1 Compositions and methods for modulating melanin production |
| 04/16/1998 | WO1998015275A2 Method and potentiated composition for treating migraine |
| 04/16/1998 | WO1998015273A1 Photodynamic therapy for the treatment of osteoarthritis |
| 04/16/1998 | WO1998015272A1 Method for inhibiting stress-activated protein kinases |
| 04/16/1998 | WO1998015271A1 9-substituted porphycenes |
| 04/16/1998 | WO1998015270A1 Anticonvulsant derivatives useful in treating neuropathic pain |
| 04/16/1998 | WO1998015268A1 Pharmaceutical microspheres of valproic acid for oral administration |
| 04/16/1998 | WO1998015267A1 Method for the treatment of neurological or neuropsychiatric disorders |